alpha-Tokoferol | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Alpha-Tokoferol
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

alpha-Tokoferol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 10 USDMF, 4 CEP/COS, 9 JDMF, 14 Listed Suppliers, $ API Reference Price

31 API Suppliers
10 USDMF
4 CEP/COS
9 JDMF
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

123 FDF Dossiers, 11 FDA Orange Book, 12 Europe, 2 Canada, 25 South Africa, 73 Listed Dossiers

123 FDF Dossiers
11 FDA Orange Book
12 Europe
2 Canada
25 South Africa
73 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 5 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 4 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 2 Bioplus Life Sciences, 1 CD Formulation, 8 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 2 Ideal Cures, 3 Ingredion Pharma Solutions, 4 Kerry, 2 Keval Exports, 3 Lonza Capsugel, 2 Lubrizol Life Science Health, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 23 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 30 Thickeners and Stabilizers, 24 Topical, 23 Coating Systems & Additives, 21 Solubilizers, 18 Parenteral, 17 Lubricants & Glidants, 17 Disintegrants & Superdisintegrants, 17 Direct Compression, 14 Controlled & Modified Release, 12 Film Formers & Plasticizers, 12 Granulation, 12 Taste Masking, 11 Co-Processed Excipients, 10 Emulsifying Agents, 8 Empty Capsules, 6 Chewable & Orodispersible Aids, 3 API Stability Enhancers, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents

43 Fillers, Diluents & Binders
30 Thickeners and Stabilizers
24 Topical
23 Coating Systems & Additives
21 Solubilizers
18 Parenteral
17 Lubricants & Glidants
17 Disintegrants & Superdisintegrants
17 Direct Compression
14 Controlled & Modified Release
12 Film Formers & Plasticizers
12 Granulation
12 Taste Masking
11 Co-Processed Excipients
10 Emulsifying Agents
8 Empty Capsules
6 Chewable & Orodispersible Aids
3 API Stability Enhancers
3 Surfactant & Foaming Agents
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 7 News #PharmaBuzz

1 Data Compilation #PharmaFlow
7 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 Regulatory FDF Prices, 3 Annual Reports

5 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

38 APIs, 3 EXCIPIENTS

38 APIs
3 EXCIPIENTS

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 5 JP

2 EDQM
5 JP

ANALYTICAL

7 Analytical Methods

7 Analytical Methods

$ API Ref.Price (USD/KG) : 20 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2GlaxoSmithKline Inc.

filter Patent Reset all filters

2 All

01 12583555

02 12616210

filter Product Reset all filters

2 All

01 2HAEMAGGLUTININ-STRAIN A (H5N1) | SQUALENE | DL-ALPHA TOCOPHEROL | POLYSORBATE 80

filter Dosage Reset all filters

2 All

01 2EMULSION

filter Exp Date Reset all filters

2 All

01 12020-09-27

02 12027-03-30

Product Main Page

01

GlaxoSmithKline Inc.

Squalene API, Vitamin E, Polysorbate API

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-09-27

Date Granted : 2014-05-06

Squalene API, Vitamin E, Polysorbate API

Brand Name : AREPANRIX H5N1

Patent Number : 2616210

Filing Date : 2000-09-27

Strength per Unit : 3.75?g / 0.5mL; 10.69mg / 0.5mL; 11.86mg / 0.5mL;

Dosage Form : EMULSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2020-09-27

Date Granted : 2014-05-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

Squalene API, Vitamin E, Polysorbate API

Peptide Process CMC

Not Confirmed

GlaxoSmithKline Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-03-30

Date Granted : 2020-01-07

Squalene API, Vitamin E, Polysorbate API

Brand Name : AREPANRIX H5N1

Patent Number : 2583555

Filing Date : 2007-03-30

Strength per Unit : 3.75?g / 0.5mL; 10.69mg / 0.5mL; 11.86mg / 0.5mL;

Dosage Form : EMULSION

Human Or VET : Human

Route of Administration : INTRAMUSCULAR

Patent Expiration Date : 2027-03-30

Date Granted : 2020-01-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!